38
Participants
Start Date
August 31, 2009
Primary Completion Date
March 31, 2018
Study Completion Date
March 31, 2018
dalteparin
dalteparin subcutaneous injection
MedStar Georgetown University Hospital, Washington D.C.
Hospital HM Universitario Monteprincipe Servicio de Farmacia, Boadilla del Monte
Hospital HM Universitario Monteprincipe, Boadilla del Monte
Nemours Children's Clinic, Jacksonville
Wolfson Children's Hospital, Jacksonville
Investigational Drug Service Tampa General Hospital, Tampa
Tampa General Hospital Center of Research Excellence, Tampa
Tampa General Hospital, Tampa
University of South Florida, Tampa
St. Joseph's Children's Hospital of Tampa, Tampa
St. Jude Children's Research Hospital, Memphis
Children's Hospital of Michigan, Detroit
Children's Mercy Hospitals and Clinics, Kansas City
Texas Children's Cancer and Hematology Centers, Houston
Texas Children's Hospital Investigational Pharmacy Services, Houston
Texas Children's Hospital, Houston
El Paso Children's Hospital, El Paso
Texas Tech University Health Sciences Center El Paso, El Paso
Children's Hospital Colorado, Aurora
SBHI of Moscow city Morozovskaya Children City Clinical Hospital of Moscow city, Moscow
FSBEI HE Kazan SMU of Minzdrav Russia, Kazan'
"SAHI Children's Republican Clinical Hospital of the Ministry of", Kazan'
Sykehusapoteket Oslo, Oslo
Oslo universitetssykehus HF, Oslo
Lekarna, Univerzitetni klinicni center Ljubljana, Ljubljana
Pediatricna klinika, Univerzitetni Klinicni Center Ljubljana, Ljubljana
Lead Sponsor
Pfizer
INDUSTRY